2023-09-23-PitchBook-心血管疾病与心脏健康风险投资市场快照（英）_20页_1mb

Cardiovascular Disease & Heart Health VC Market Snapshot Summary

Cardiovascular Disease (CVD) is the leading cause of death globally and in the US, accounting for 12% of US healthcare spending. The market for cardiovascular care solutions is estimated at $300B+, growing to $400B by 2030 (4.0% CAGR). VC-backed startups have raised over $20B since 2020.

The ecosystem includes:

• Market Segments: Patient monitoring, devices & implants, cardiac imaging, chronic condition management, biopharmaceuticals
• VC Activity: $3.5B+ raised annually from 2020-2022; key deals include HeartFlow ($215M), Cleerly ($192M), Cardurion Pharma ($300M)
• Exit Activity: Acquisition-dominated with large deals like AskBio ($3B Bayer acquisition)
• Opportunities: Remote patient monitoring, digital hypertension/weight loss solutions (driven by GLP-1 drugs), AI imaging analysis, minimally invasive surgical tech, gene therapies

Key challenges include:

• Weight loss drug commercialization barriers
• Competition from consumer wearables
• Solution fatigue in saturated markets

The market segmentation covers detailed categories under each VC segment and biopharmaceutical approaches. This comprehensive analysis highlights significant growth potential across digital health, AI applications, and novel therapeutics in cardiovascular care.

Published September 7, 2023
©2023 PitchBook Data, Inc.